Medicines Company v. Hospira, Inc., No. 14-1469 (Fed. Cir. Feb. 6, 2018)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

The Medicines Company appeals findings of no i n- fringement made by the United States District Court for the District of Delaware. Hospira cross -appeals the district court’s finding that a d istribution agreement did not constitute an invalidating “offer for sale” under 35 U.S.C. § 102(b). We af firm the district court’s noni n- fringement findings and remand the case for the district court to determine whether the on-sale bar applies. I The Medicines Company owns U.S. Patent Nos. 7,582,727 and 7,598,343.